Merck's COVID-19 pill to arrive in Israel within two weeks
Molnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus in adults.
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021.(photo credit: MERCK & CO INC/HANDOUT VIA REUTERS)Updated: 
